Published in Medical Devices and Surgical Technology Week, June 22nd, 2008
"FDA clearance of the Abiomed Impella 2.5 represents the next step in enabling heart recovery for patients in the U.S. and will likely change the standard of care in the catheterization lab," said Michael R. Minogue, Chairman, Chief Executive Officer and President of Abiomed. "The device seamlessly provides immediate, minimally...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week